This is a patient-reported outcome performance measure (PRO-PM) consisting of a patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients aged 14 years and older with lymphedema or other causes of edema. For patients with such conditions affecting the arm, hand, chest, or breast body regions, the change in FS is assessed using the FOTO Upper Quadrant Edema (UQE) FS PROM.1 For patients with such conditions affecting the leg, foot, groin, or lower trunk regions, the change in FS is assessed using the FOTO Lower Quadrant Edema (LQE) FS PROM.2 PROM scores were scaled to the 0-100 metric, with higher scores representing higher perceived functional status.
To fairly measure performance between providers, the measure is risk-adjusted to patient characteristics known to be associated with FS outcomes and used as a performance measure at the patient and provider levels to assess quality.
This is a patient-reported outcome performance measure (PRO-PM) consisting of a patient-reported outcome measure (PROM) of risk-adjusted functional status (FS) change in balance confidence for patients aged 14+ with balance impairments. The change in FS is assessed using the FOTO Balance Confidence, an item-response theory-based PROM derived from the 16-items of the Activities-specific Balance Confidence (ABC) Scale©, (1-3) scored using the T-score metric (mean=50, SD=10), with higher scores representing higher balance confidence.(4)
Patient responses to ABC Scale© items may be used to directly score Balance Confidence PROM, thus allowing clinicians flexibility of choice of PROM used in routine clinical care without adding to patient response burden. In order to fairly measure performance between providers, this quality measure is risk-adjusted to patient characteristics known to be associated with FS outcomes and used as a performance measure the patient and provider levels to assess quality.
This is a patient-reported outcome performance measure (PRO-PM) consisting of a patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients aged 14 years and older who have experienced a stroke with sequelae impacting physical functional abilities. For patients with such conditions affecting use of the hand, arm, and upper trunk, the change in FS is assessed using the FOTO Stroke Upper Extremity (SUE) FS PROM.1 For patients with such conditions affecting the foot, leg, and lower trunk, the change in FS is assessed using the FOTO Stroke Lower Extremity (SLE) FS PROM.1 PROM cores were scaled to the 0-100 metric, with higher scores representing higher perceived functional status. In order to fairly measure performance between providers, the measure is risk-adjusted to patient characteristics known to be associated with FS outcomes and used as a performance measure (PM) at the patient and provider levels to assess quality.
This is a patient-reported outcome performance measure (PRO-PM) consisting of a patient-reported outcome measure (PROM) of risk-adjusted functional status (FS) change in jaw functional status for patients aged 14+ with impairments related to jaw function. The change in FS is assessed using the FOTO Jaw Functional Status Scale (JFSS), an item-response theory (IRT)-based PROM derived from 13 of the 20 items of the Jaw Functional Limitation Scale (JFLS).1, 2 The JFLS is a condition-specific PROM for functional limitations in the masticatory system.3 The 13-item FOTO JFSS is scored using the T-score metric (mean=50, SD=10), with higher scores representing higher functional status. The JFSS PROM can be administered using either computerized adaptive test (CAT)4 or a 6-item short form.
In order to fairly measure performance between providers, this quality measure is risk-adjusted to patient characteristics known to be associated with FS outcomes and used as a performance measure at the patient and provider levels to assess quality.
Percentage of patients with patient-reported meaningful improvement in anatomic specific HOOS/KOOS JR after elective total hip and knee arthroplasty.
Percentage of patients with patient-reported meaningful improvement in pain following lumbar or cervical spine procedures
Percentage of patients, aged 18 and older, who were surveyed on their patient experience and satisfaction with anesthesia care and who reported a positive experience.
This measure will consist of two performance rates:
AQI48a: Percentage of patients, aged 18 and older, who were surveyed on their patient experience and satisfaction with anesthesia care
AQI48b: Percentage of patients, aged 18 and older, who completed a survey on their patient experience and satisfaction with anesthesia care who report a positive experience with anesthesia care within 60 days of receipt of the survey.
NOTE: The measure requires that a valid survey, as defined in the numerator of AQI48a, be sent to patients between discharge from the facility and within 30 days of facility discharge. To report AQI48b, a minimum number of 20 surveys with the mandatory question completed must be reported. ** In order to be scored on this measure, clinicians must report BOTH AQI48a AND AQI48b.
Percentage of adult patients (greater than or equal to 18 years old) who self-report favorable outcomes resulting from a recommended treatment or management approach for Actinic Keratosis (AK) and who self-report satisfaction with the treatment or management of AK. Patients provide a global assessment of the perceived effectiveness of the AK treatment or management plan, followed by their satisfaction and future treatment preference. Evaluating both treatment effectiveness and patient satisfaction supports patient-provider communication and promotes patient-centered approaches to AK care.
The percentage of top-box responses among patients aged 18 years and older who had an ambulatory palliative care visit and report feeling heard and understood by their palliative care clinician and team within 2 months (60 days) of the ambulatory palliative care visit.
The percentage of patients aged 18 and older with a mental and/or substance use disorder who demonstrated improvement or maintenance of functioning based on results from the 12-item World Health Organization Disability Assessment Schedule (WHODAS 2.0) or Sheehan Disability Scale (SDS) 30 to 180 days after an index assessment.